Clinical genetics of malignant melanoma

Journal Title: Postępy Nauk Medycznych - Year 2010, Vol 23, Issue 11

Abstract

Malignant melanoma (MM) represents one of the most aggressive neoplasms and its frequency is increasing rapidly. Increased melanoma risk among relatives of MM patients and familial aggregations of this malignancy point at genetic predisposition as an important factor of MM pathogenesis. Familial MM constitutes most probably a heterogenous group of disorders characterized by occurrence of MM among relatives. The mode of inheritance is controversial and most likely polygenic, however not infrequently, within large families aggregations of MM is consistent with autosomal dominant inheritance.The genetic basis of MM is complex and appears to involve multiple genes. CDKN2A is regarded as the major MM susceptibility gene. In the Polish population common CDKN2A variant (A148T) increases significantly melanoma risk regardless of the cancer family history. Mutations of other high risk genes, ARF and CDK4 are extremely rare and thus clinically insignificant. In majority of MM cases CDKN2A mutations are not found. It is thus necessary to perform association studies focused on identifying genetic markers that could be used in identifying patients with a high risk of MM. List of other genes that carry mutations, which are believed to be associated with moderate MM risk include XPD, MC1R, BRCA2. The management with individuals being at increased MM risk involves clinical screening according to carefully planned surveillance schedule and early treatment of MM tumour. The appropriate management may reduce morbidity and mortality. Genetic testing and clinical evaluation should be performed, and family history should be obtained in all patients affected with MM, also in those with apparently sporadic tumours.

Authors and Affiliations

Tadeusz Dębniak, Jan Lubiński

Keywords

Related Articles

Zaczerwienienie twarzy – problem interdyscyplinarny. Nietolerancja histaminy w przebiegu niedoboru diaminooksydazy

70-letnia kobieta ze stale występującymi: zaczerwienieniem twarzy, uczuciem parzenia policzków, diagnozowana była przed kilkoma laty w Klinice Endokrynologii z podejrzeniem rakowiaka. Okresowo występowały również bóle gł...

Introduction of maternal and foetal morphological parameters of blood for calculation the postpartum anti-RhD immunoglobulin doses

<b>Introduction.</b> Doses of anti-RhD Ig for immunoprophylaxis of haemolytic disease of newborn (HDN) are established with reference to the volume of RhD positive foetal red blood cells in th...

Identyfikacja pałeczek Gram-ujemnych z rodziny Enterobacteriaceae przy użyciu spektrometrii masowej MALDI-TOF

Wstęp. Spektrometria masowa z użyciem desorpcji/jonizacji laserowej wspomaganej matrycą z analizatorem czasu przelotu (ang. matrix assisted laser ionization-time of flight mass spectrometry – MALDI-TOF MS) jest nową meto...

Guz Buschke-Lowensteina – trudny problem interdyscyplinarny

Kłykciny olbrzymie, czyli guz Buschke-Loewensteina jest chorobą spowodowaną infekcją wirusem HPV typu 6 i 11, rzadziej 16 i 18, 54 i wg klasyfikacji WHO zaliczany jest do nowotworów brzegu odbytu. Czynnikami ryzyka zacho...

Download PDF file
  • EP ID EP53781
  • DOI -
  • Views 209
  • Downloads 0

How To Cite

Tadeusz Dębniak, Jan Lubiński (2010). Clinical genetics of malignant melanoma. Postępy Nauk Medycznych, 23(11), -. https://europub.co.uk/articles/-A-53781